Clinical Trial Update: A Trial of Hepatic Arterial Infusion Combined With Apatinib and Camrelizumab Versus Apatinib and Camrelizumab for C-staged Hepatocellular Carcinoma in BCLC Classification [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing hepatic arterial infusion with Apatinib and Camrelizumab versus Apatinib and Camrelizumab for C-staged hepatocellular carcinoma (BCLC)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Sun Yat-sen University | Conditions: C-staged Hepatocellular Carcinoma in BCLC Classification | Phase 3 | Status: UNKNOWN